Echeverri-Toro Lina María, Penagos Sara, Castañeda Laura, Villa Pablo, Atehortúa Santiago, Ramírez Faiver, Restrepo Carlos, Ospina Sigifredo, Agudelo Yuli, Hidrón Alicia, Agudelo Paola, Valderrama Eliana, Agudelo Carlos Andrés
Servicio de Microbiología Médica, Hospital Universitario de San Vicente Fundación, Medellín, Colombia Servicio de Microbiología Médica y Enfermedades Infecciosas, Centros Especializados de San Vicente Fundación, Medellín, Colombia.
Biomedica. 2017 Jan 24;37(1):62-67. doi: 10.7705/biomedica.v37i1.3280.
Leptospirosis remains a significant health problem in tropical regions including Latin America, where its presentation is 100 times higher than that observed in other regions of the world. Mortality reaches 10% in severe cases. Its diagnosis is challenging because clinical manifestations during the initial phase are non-specific and because of limited availability of diagnostic tests.
To describe the demographic and clinical characteristics and the outcomes in hospitalized patients with leptospirosis.
This retrospective study included patients treated at four institutions in Medellín between January, 2009, and December, 2013, with a compatible clinical picture and a positive IgM for Leptospira spp.
We included 119 patients, 80% male, and 58% of rural origin. The mean duration of symptoms was 9.6 days (SD=9.6). Eighty nine per cent of patients had fever; 62%, jaundice; 74%, myalgia; 46%, diarrhea; 41%, hepatomegaly; 13%, splenomegaly, and 13%, conjunctival injection. Fifty four per cent of patients had impaired renal function; 32%, pulmonary compromise, and 13%, liver failure. Sixteen per cent required admission to the ICU; 12%, mechanical ventilation, and 11%, vasopressor therapy.Weil's syndrome occurred in 38.6% and 5% died. The average hospital stay was 11 days (SD=9.6).
In this population, the clinical manifestations and complications of leptospirosis were similar to those reported in the literature. We observed a relatively low overall mortality in relation to global statistics.